We are monitoring the impact of COVID-19 on Immunoassay Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1488
Share on
Share on

Global Immunoassay Market Size, Share, Trends and Growth Analysis Report – Segmented By Technology, Application, End-User and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1488
Pages: 182

Global Immunoassay Market Size (2020 to 2025)

The size of the global immunoassay market was worth USD 19.81 Billion in 2020. It is estimated to reach USD 31.62 Billion by the end of 2025, with a CAGR of 9.8% during the forecast period.

Immunoassay is a procedure used to identify and measure properties antibodies and antigens in proteins and other substances. Immunologic assays depend entirely on the reactions with the help of immunologic agents, which are highly necessary for the response to take place. These are used to measure the number of analytes in serum and urine for therapeutic and analysis objectives. It is also employed in qualitative, quantitative, and radioactivity methods to secure the accuracy of outcomes. High sensitivity and specificity of immunoassays are used to catalyze the reactions.

MARKET DRIVERS

Growing rates of chronic & contagious disease and increasing use of immunoassays in Oncology are majorly driving the growth of the global immunoassay market.

The rise in demand for point of care testing devices and the increasing adoption rate of these devices boost the growth of the immunoassay market. Steadily rising incidence of infections and chronic diseases is also propelling the growth of the Global Immunoassay Market. The availability of adequate and sensitive diagnostics tests is also fuelling the growth rate of the Immunoassay market. The factors such as increasing awareness among people regarding the point of care devices and government initiatives on developing testing devices contribute to the growth of the Global Immunoassay Market. 

Intensive focus on initiatives from the private and public organizations for developing cost-effective drugs and enhancing the efficiency of therapies are expected to create more growth opportunities for the Global Immunoassay Market over the forecast period. The increasing adoption rate of companion diagnostics, which can assist professionals in making decisions by analyzing the patient response to the therapy, is presumed to offer growth opportunities for the market stakeholders during the forecast period. Increasing prevalence of diseases such as tuberculosis, HIV, hepatitis C, dengue among people due to biological factors are boosting the number of opportunities for the growth of the Immunoassay market. Also, improving the approval processes of a novel device to develop therapeutic procedures is anticipated to create growth opportunities for the global Immunoassay Market stakeholders. Increasing demand for safer drugs and specialist therapies across the world is likely to create lucrative opportunities for market players in the region during the forecast period.

MARKET RESTRAINTS

The inappropriate functioning of regulatory bodies with stringent rules is a significant challenge for key players in the market, obstructing the growth of the global Immunoassay Market. Other factors that are restraining the development of the immunoassay market are continually changing reimbursement policies, and assay procedures are highly complicated.

Impact of COVID-19 on Immunoassay Market

The COVID-19 pandemic has negatively affected many countries across the globe. Several measures introduced to deal with the pandemic, such as lockdowns, reduction in trade activities, and shutdown of multiple factories and workplaces in several countries, could save lives; however, these measures have wide-ranging economic effects inducing economic contagion. Along with the risk of a slowdown of global growth, the results of COVID-19 are adversely affecting various economic sectors in economies across the globe.

Key manufacturing segments have halted operations across the globe in response to the lockdown regulations issued by governments of various countries and discontinuing public transport services.

End-users of Immunoassay Market worldwide are facing concerns due to government-imposed lockdowns due to the COVID-19 pandemic. It has hampered the manufacture of products. The COVID-19 pandemic impact is estimated to be high on the Immunoassay Market in 2020 and 2021.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Technology, Application, End Users and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific, Abbott Laboratories, Akers Biosciences, Inc., Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe) and Intrinsic LifeSciences

 

This research report on the global immunoassay market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.

Immunoassay Market - By Technology:

  • Enzyme Immunoassays
  • Fluorescent Immunoassays
  • Chemiluminescence Immunoassays
  • Nephelometric Immunoassays
  • Radio Immunoassays
  • Counting Immunoassays
  • Turbidimetric Immunoassays

Immunoassay Market - By Application:

  • Oncology
  • Cancer
  • Hematology
  • Cardiology
  • Thyroid
  • Infectious diseases
  • Allergies

The infection disease segment dominates the market by contributing significant revenues and maintaining the trend during the forecast period based on the application. It is due to the increasing account of infections such as salmonella infections, Lyme disease among people across the world, which is leading to the increased adoption rate of Immunoassay for the detection of these diseases.

Immunoassay Market - By End User:

  • Hospitals
  • Clinics
  • Academic Research Institute
  • Pharmaceutical
  • Biotech vendors
  • Laboratories

The hospital segment was valued for the largest market share of about 29.8% in 2019, as they offer excellent facilities that incorporate in-house diagnostic laboratories. With an increase in the prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune diseases, the need for hospitals and diagnostic centers for the detection of antigens in cancer cells has increased.

Clinical laboratories are also increasingly adopting immunoassays, such as immunohistochemical staining. Furthermore, it grew the need for diagnostic centers and clinical laboratories with advanced instruments to perform such tests, thereby supplementing the market growth.

Immunoassay Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America accounted for the largest share in the market due to the increasing adoption of low-cost immunoassay instruments in research and clinical laboratories, rising immunoassay techniques in cancer research, and increasing infrastructure for a laboratory.

The Asia-pacific market is expected to show high CAGR over the forecast period. The expected growth is attributed to increasing development of new biologics, drugs, and vaccines, a large number of investment opportunities in these immature/emerging markets, rising diagnostics laboratories in this region, growing government and corporate investment in the pharmaceutical and biotechnology segment, increasing focus on attracting international and domestic leaders in the Global Immunoassay Market.

NOTABLE COMPANIES IN THE MARKET

Some of the most promising companies leading the Global Immunoassay Market profiled in this report are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific, Abbott Laboratories, Akers Biosciences, Inc., Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe) and Intrinsic LifeSciences.

KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

In 2019, Abbott laboratories developed a fully automated immunoassay analyzer called Abbott Prism and worked on Chia technology. It is highly useful for screening blood with practical outcomes. Other benefits of these systems are cGMP compliant, error reduction owing to the tamper resistance offered by the network, less intervention of humans as the system takes care of the monitoring, processing, and documentation, improved lab efficiency.

In July 2018, Cygnus technologies collaborated with the Gyros Protein Technologies to develop immunoassay kits to detect biotherapeutics' impurities. The strategic partnership between the two will focus mainly on providing bioanalytical solutions for customers and enhancing productivity in biotherapeutics manufacturing.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Technology

                                5.1.1 Introduction

                                5.1.2 Enzyme Immunoassay

                                5.1.3 Fluorescent Immunoassays

                                5.1.4 Cheniluminescence Immunoassays

                                5.1.5 Nephelometric Immunoassays

                                5.1.6 Radio Immunoassays

                                5.1.7 Counting Immunoassays

                                5.1.8 Counting Immunoassays

                                5.1.9 Others

                                5.1.10 Y-o-Y Growth Analysis, By Technology

                                5.1.11 Market Attractiveness Analysis, By Technology

                                5.1.12 Market Share Analysis, By Technology

                5.2 Application 

                                5.2.1 Introduction

                                5.2.2 Oncology

                                5.2.3 Cancer

                                5.2.4 Hematology

                                5.2.5 Cardiology

                                5.2.6 Thyroid

                                5.2.7 Infectious disease

                                5.2.8 Allergies

                                5.2.9 Others

                                5.2.10 Y-o-Y Growth Analysis, By Application

                                5.2.11 Market Attractiveness Analysis, By Application

                                5.2.12 Market Share Analysis, By Application

                5.3 End users    

                                5.3.1 Introduction

                                5.3.2 Hospitals

                                5.3.3 Clinics

                                5.3.4 Academic research institutes

                                5.3.5 Pharmaceutical and Biotech vendors

                                5.3.6 Laboratories

                                5.3.7 Others

                                5.3.8 Y-o-Y Growth Analysis, By End users

                                5.3.9 Market Attractiveness Analysis, By End users

                                5.3.10 Market Share Analysis, By End users

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.4 Market Attractiveness Analysis

                                6.1.5 Market Share Analysis

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Diagnostics    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 DiaSorin S.p.A           

                8.3 Beckman Coulter     

                8.4 Siemens Healthcare

                8.5 Ortho Clinical Diagnostics     

                8.6 bioMerieux

                8.7 Thermo Fisher Scientific        

                8.8 Abbott Laboratories

                8.9 Akers Biosciences    

                8.10 Becton Dickinson and Company      

                8.11 Devon Medical Products    

                8.12 EDP Biotech Corporation    

                8.13 Hologic       

                8.14 Intrinsic LifeSciences           

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Global Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  2. Global Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  3. Global Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  4. Global Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  5. Global Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  6. Global Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  7. Global Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  8. Global Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  9. Global Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  10. Global Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  11. Global Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  12. Global Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  13. Global Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  14. Global Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  15. Global Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  16. Global Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  17. Global Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  18. Global Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  19. Global Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  20. Global Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  21. Global Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  22. Global Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  23. Global laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  24. North America Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  25. North America Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  26. North America Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  27. North America Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  28. North America Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  29. North America Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  30. North America Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  31. North America Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  32. North America Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  33. North America Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  34. North America Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  35. North America Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  36. North America Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  37. North America Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  38. North America Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  39. North America Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  40. North America Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  41. North America Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  42. North America Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  43. North America Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  44. North America Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  45. North America laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  46. United States Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  47. United States Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  48. United States Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  49. Canada Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  50. Canada Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  51. Canada Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  52. Europe Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  53. Europe Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  54. Europe Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  55. Europe Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  56. Europe Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  57. Europe Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  58. Europe Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  59. Europe Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  60. Europe Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  61. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  62. Europe Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  63. Europe Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  64. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  65. Europe Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  66. Europe Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  67. Europe Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  68. Europe Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  69. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  70. Europe Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  71. Europe Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  72. Europe Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  73. Europe laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  74. U.K. Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  75. U.K. Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  76. U.K. Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  77. Germany Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  78. Germany Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  79. Germany Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  80. France Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  81. France Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  82. France Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  83. Italy Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  84. Italy Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  85. Italy Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  86. Spain Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  87. Spain Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  88. Spain Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  89. Asia-Pacific Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  90. Asia-Pacific Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  91. Asia-Pacific Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  92. Asia-Pacific Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  93. Asia-Pacific Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  94. Asia-Pacific Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  95. Asia-Pacific Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  96. Asia-Pacific Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  97. Asia-Pacific Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  98. Asia-Pacific Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  99. Asia-Pacific Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  100. Asia-Pacific Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  101. Asia-Pacific Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  102. Asia-Pacific Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  103. Asia-Pacific Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  104. Asia-Pacific Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  105. Asia-Pacific Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  106. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  107. Asia-Pacific Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  108. Asia-Pacific Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  109. Asia-Pacific Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  110. Asia-Pacific laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  111. Japan Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  112. Japan Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  113. Japan Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  114. China Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  115. China Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  116. China Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  117. India Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  118. India Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  119. India Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  120. Latin America Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  121. Latin America Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  122. Latin America Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  123. Latin America Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  124. Latin America Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  125. Latin America Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  126. Latin America Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  127. Latin America Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  128. Latin America Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  129. Latin America Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  130. Latin America Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  131. Latin America Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  132. Latin America Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  133. Latin America Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  134. Latin America Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  135. Latin America Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  136. Latin America Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  137. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  138. Latin America Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  139. Latin America Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  140. Latin America Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  141. Latin America laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  142. Brazil Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  143. Brazil Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  144. Brazil Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  145. Rest of Latin America Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  146. Rest of Latin America Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  147. Rest of Latin America Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  148. Middle East & Africa Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  149. Middle East & Africa Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  150. Middle East & Africa Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  151. Middle East & Africa Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  152. Middle East & Africa Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  153. Middle East & Africa Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  154. Middle East & Africa Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  155. Middle East & Africa Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  156. Middle East & Africa Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  157. Middle East & Africa Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  158. Middle East & Africa Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  159. Middle East & Africa Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  160. Middle East & Africa Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  161. Middle East & Africa Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  162. Middle East & Africa Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  163. Middle East & Africa Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  164. Middle East & Africa Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  165. Middle East & Africa Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  166. Middle East & Africa Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  167. Middle East & Africa Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  168. Middle East & Africa Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  169. Middle East & Africa laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  170. Middle East Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  171. Middle East Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  172. Middle East Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  173. Africa Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  174. Africa Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  175. Africa Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample